Tamoxifen citrate Prescribing at RYDAL
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
56
Total Quantity
3,206
NHS Cost
£522
vs National Avg
-32%
RYDAL prescribed 56 items of Tamoxifen citrate over the last 12 months at a cost of £522 to the NHS. This is 32% below the national average prescribing rate. Tamoxifen citrate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jul 2026
6
Jul 2026
5
Jul 2026
3
Jul 2026
6
Jul 2026
4
Jul 2026
3
Jul 2026
6
Jul 2026
6
Jul 2026
2
Jul 2026
9
Jul 2026
2
Jul 2026
4
Prescribing Details
| Total Items | 56 |
|---|---|
| Total Quantity | 3,206 |
| Total NHS Cost | £522 |
| Presentations | 2 different forms |
| vs National Average | -32% |
Tamoxifen citrate Prescribing Comparison
| This practice | 56 items |
|---|---|
| National average per practice | 82 items |
| Difference | -32% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.